<DOC>
	<DOCNO>NCT00302328</DOCNO>
	<brief_summary>The project randomize clinical trial follow time 12 month compare effect surgical treatment idiopathic macular hole . Patients randomized vitrectomy alone , vitrectomy plus indocyanine green ( ICG ) assist inner limit membrane ( ILM ) peel vitrectomy plus trypan blue ( tb ) assist ILM peel . At baseline patient characterize use early treatment diabetic retinopathy study ( ETDRS ) visual chart , test aniseikonia , optical coherence tomography 3 ( OCT3 ) , visual field fundus photography . Per- postoperative complication register . Data analyse help clarify effect ILM peeling hole closure visual acuity . Comparing result ICG- tb assist ILM peel help clarify topic toxic effect retinal cell stain peel ILM . Changes intraretinal morphology dye-assisted ILM peeling study use OCT3 image patient ' subjective opinion surgical result analyze use quality life questionnaires metamorphopsia test .</brief_summary>
	<brief_title>Trial Prognostic Factors Surgical Methods Treatment Idiopathic Macular Holes</brief_title>
	<detailed_description />
	<mesh_term>Retinal Perforations</mesh_term>
	<criteria>Idiopathic macular hele stage 2 3 . Duration Symptoms ≤ 12 month . Visual acuity ≥ 34 ETDRS letter . Intraocular pressure ≤ 23 mmHg . Informed consent . Previous macular hole project eye Macular pucker bad cellophane macular reflex . Previous surgery disease eye affect retinal function . Systemic disease affection vision include diabetes mellitus level retinopathy ≥ 14a . Amblyopia project eye .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>